Prescription service

Nu Image Medical review

Nu Image Medical offers injection, rapid-dissolve and nasal sermorelin formats from an advertised $169 monthly figure. Format convenience is meaningful, but equal pricing does not establish equivalent evidence.

A closer look at the service.

Read the consultation, follow-up and payment terms before taking the next step.

Visit Nu Image MedicalOfficial provider website. No affiliate relationship is currently listed.

Who should look closer

Readers who want to discuss several delivery formats with a licensed prescriber and compare their actual terms.

Reasons to pause

People assuming an oral tablet or nasal spray can borrow the outcomes of an injected GHRH experiment.

In this review

The route choice is the distinguishing feature

Nu Image Medical’s peptide menu lists sermorelin injections, rapid-dissolve tablets and nasal spray. [1] That range is the main reason to consider it. Someone who finds injections impractical may value the opportunity to discuss another format. I would keep the clinical question separate from that convenience. The same active name does not establish equivalent exposure, effectiveness or evidence across three routes. The service becomes more useful when the clinician explains those distinctions rather than presenting format choice as a purely cosmetic preference. A reader should know what is being traded as well as what becomes easier.

As low as needs the selected plan

The menu advertises the formats as low as $169 per month. [1] That phrase needs the selected supply and agreement beside it. Ask what qualifies for the lowest rate, the actual amount due now and which visits, laboratory work or delivery charges are included. Confirm whether a longer commitment or larger initial supply is required. I would not assume the same headline means the same preparation, useful duration or payment schedule for every patient. A clear route comparison should also be a clear cost comparison. Otherwise, the apparent simplicity of equal prices can hide meaningful differences in what is supplied.

A needle-free format needs its own evidence

Adult GHRH experiments using an injected preparation do not establish the results of a rapid-dissolve tablet or nasal product. [2] That does not prove a different format can never work; it identifies the evidence that would be needed to support equivalence. Ask whether the service has applicable pharmacokinetic or outcome data for the actual preparation. A tablet dissolving quickly is a practical property, not a demonstrated clinical result. I would give credit to an honest explanation of uncertainty and avoid choosing a route because its name appears beside a familiar injection study. Evidence should follow the formulation being prescribed.

Compounded status should stay visible

The official peptide page identifies the products as compounded and prescription-only and explains that compounded drugs are not reviewed or approved by the FDA for safety, effectiveness or quality. [1] That is an important part of the product description. A licensed pharmacy and medical evaluation provide accountability, but they do not convert the preparation into an approved finished drug. Ask for the actual dispensing pharmacy, ingredients and label instructions. I would keep those details with the agreement, especially when comparing non-injection formats whose formulation may vary. A broad assurance of professional oversight should not substitute for knowing which preparation is being considered.

Support must match the actual preparation

Nu Image describes provider assessment, delivery and ongoing support. [1] Before enrollment, make the support specific to the selected format: who handles storage or use questions, how a symptom reaches a clinician and how a plan is reconsidered if the expected benefit does not occur. Different delivery methods create different practical questions, so generic customer service is not the complete answer. The agreement should also explain renewal, cancellation and treatment of already prepared medication. I would prefer a clearly supported route with realistic expectations over a more convenient-looking option whose evidence and follow-up remain vague.

My verdict separates convenience from equivalence

Nu Image Medical is a relevant comparison for readers who want to discuss several sermorelin delivery formats under one service. Its limitation is the temptation to treat route choice as evidence-neutral because the advertised starting figure is similar. Compare the actual written plan with another service offering the same route, then examine whether the evidence supports the intended purpose. A favorable purchase would require a clear pharmacy, complete quote and explanation of formulation-specific uncertainty. Convenience can justify interest. It cannot on its own justify assuming a tablet, spray and injection produce the same meaningful clinical result.

Understanding the cost

Menu advertises formats as low as $169/month. Confirm selected route, amount, qualifying commitment, included care and complete delivered charge. [1]

Build your cost estimate

Sources

  1. Nu Image Medical: official product and service information
  2. Vittone et al. (1997): nightly GHRH 1–29 in older men

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.